RPRX CIK: 1802768

Royalty Pharma plc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.02
FY22:
2.14
FY23:
2.99
FY24:
2.77
FY25:
2.49
Change from FY21 to FY25
billions USD
FY21:
−1.87
FY22:
−1.03
FY23:
−2.07
FY24:
−2.68
FY25:
−1.61
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
−0.94
FY23:
−2.15
FY24:
0.36
FY25:
−1.19
billions USD
FY21:
0.53
FY22:
0.17
FY23:
−1.23
FY24:
0.45
FY25:
−0.31

All amounts in billions USD Data source:SEC EDGAR